Xueyu Liu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Xueyu Liu

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Computers in Biology and Medicine|September 18, 2023

Diagnosis of diabetic kidney disease in whole slide images via AI-driven quantification of pathological indicatorsXueyu Liu, Yongfei Wu, Yilin Chen, et al.

Journal of Lipid Research|November 23, 2012

Measurement of LDL-C after treatment with the CETP inhibitor anacetrapibMichael Davidson, Sherry Xueyu Liu, Philip Barter, et al.

IEEE Journal of Biomedical and Health Informatics|March 25, 2024

MSMTSeg: Multi-Stained Multi-Tissue Segmentation of Kidney Histology Images via Generative Self-Supervised Meta-Learning FrameworkXueyu Liu, Rui Wang, Yexin Lai, et al.

The New England Journal of Medicine|November 19, 2010

Safety of anacetrapib in patients with or at high risk for coronary heart diseaseChristopher P Cannon, Sukrut Shah, Hayes M Dansky, et al.

Elife|December 17, 2024

Characterization of cancer-driving nucleotides (CDNs) across genes, cancer types, and patientsLingjie Zhang, Tong Deng, Zhongqi Liufu, et al.

American Heart Journal|September 29, 2009

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapibChristopher P Cannon, Hayes M Dansky, Michael Davidson, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Computers in Biology and Medicine|September 18, 2023

Diagnosis of diabetic kidney disease in whole slide images via AI-driven quantification of pathological indicatorsXueyu Liu, Yongfei Wu, Yilin Chen, et al.

Journal of Lipid Research|November 23, 2012

Measurement of LDL-C after treatment with the CETP inhibitor anacetrapibMichael Davidson, Sherry Xueyu Liu, Philip Barter, et al.

IEEE Journal of Biomedical and Health Informatics|March 25, 2024

MSMTSeg: Multi-Stained Multi-Tissue Segmentation of Kidney Histology Images via Generative Self-Supervised Meta-Learning FrameworkXueyu Liu, Rui Wang, Yexin Lai, et al.

The New England Journal of Medicine|November 19, 2010

Safety of anacetrapib in patients with or at high risk for coronary heart diseaseChristopher P Cannon, Sukrut Shah, Hayes M Dansky, et al.

Elife|December 17, 2024

Characterization of cancer-driving nucleotides (CDNs) across genes, cancer types, and patientsLingjie Zhang, Tong Deng, Zhongqi Liufu, et al.

American Heart Journal|September 29, 2009

Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapibChristopher P Cannon, Hayes M Dansky, Michael Davidson, et al.

Pageof 6